A group of leading African researchers trying to develop effective vaccines against HIV is trying to figure out how to ...

Blog - A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt ...

The first sa-mRNA vaccine to reach any market was Gennova Biopharmaceuticals' Gemcovac, which was launched in India in 2022 on the back of an emergency approval as the pandemic was still in full ...

Objectives This study investigates the diagnostic role of synovial tissue analysis in children presenting with arthritis and assesses its prognostic significance to predict clinical outcome in ...

New York, USA, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Global Oligonucleotide Synthesis Market to Cross USD 7 Billion by 2032 | DelveInsight The increasing occurrence of genetic disorders is a major ...

New York, USA, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Global Peptide Synthesis Market to Surge at a Tremendous CAGR of ~10% by 2032 | DelveInsight The peptide synthesis market is expanding rapidly ...

In February 2025, Immix Biopharma, Inc. announced that the FDA has granted RMAT designation to its sterically-optimized CAR-T therapy, NXC-201, for the treatment of relapsed or refractory AL ...